1. Home
  2. LAES vs BNTC Comparison

LAES vs BNTC Comparison

Compare LAES & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$2.49

Market Cap

821.2M

Sector

Technology

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$10.96

Market Cap

411.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
BNTC
Founded
2022
1995
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.2M
411.4M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
LAES
BNTC
Price
$2.49
$10.96
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$4.00
$27.67
AVG Volume (30 Days)
6.5M
135.9K
Earning Date
03-31-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$93.36
N/A
Revenue Next Year
$43.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.12
$9.85
52 Week High
$8.71
$17.15

Technical Indicators

Market Signals
Indicator
LAES
BNTC
Relative Strength Index (RSI) 30.93 47.24
Support Level N/A $9.89
Resistance Level $2.88 $13.27
Average True Range (ATR) 0.23 0.59
MACD -0.05 -0.04
Stochastic Oscillator 20.43 41.99

Price Performance

Historical Comparison
LAES
BNTC

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: